Thrivent Financial for Lutherans Sells 223,120 Shares of Humana Inc. (NYSE:HUM)

Thrivent Financial for Lutherans cut its position in Humana Inc. (NYSE:HUM - Free Report) by 37.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 377,197 shares of the insurance provider's stock after selling 223,120 shares during the quarter. Thrivent Financial for Lutherans owned about 0.31% of Humana worth $95,699,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. FPC Investment Advisory Inc. bought a new stake in shares of Humana during the 4th quarter valued at $27,000. Centricity Wealth Management LLC bought a new stake in shares of Humana during the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA raised its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management bought a new stake in shares of Humana during the 4th quarter valued at $33,000. Finally, Atwood & Palmer Inc. raised its stake in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HUM shares. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Truist Financial boosted their target price on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. Royal Bank of Canada restated an "outperform" rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Finally, Barclays boosted their target price on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 13th. Eighteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $285.68.

Remove Ads

Humana Trading Down 0.2 %

HUM stock traded down $0.50 during trading on Friday, hitting $266.33. 1,963,596 shares of the company traded hands, compared to its average volume of 1,716,116. The firm has a market capitalization of $32.14 billion, a PE ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a 50-day moving average of $271.33 and a 200-day moving average of $276.92. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.33%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is presently 35.58%.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.37% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.